Image

Studying Phenotypic Risks for Obesity and Underlying Traits in Young Infants

Studying Phenotypic Risks for Obesity and Underlying Traits in Young Infants

Recruiting
2-16 years
All
Phase N/A

Powered by AI

Overview

The purpose of this research study is to understand how infants metabolize different meals and to develop clinical tools which identify infants as having two different phenotypes. The phenotypes are the 1) metabolic "thriftiness" and 2) the metabolic flexibility.

Description

The purpose of this research study is to understand how infants metabolize different meals and to develop clinical tools which identify infants as having two different phenotypes. This will be accomplished by providing two meal test stimuli to infant participants (human milk and infant formula). Energy expenditure and respiratory exchange ratio will be obtained before and after the meals to calculate the delta in both. From there, two phenotypes will be identified. The first phenotypes is metabolic "thriftiness", which will be defined by the energy expenditure after consuming two standard meals. The second phenotype is the degree of metabolic flexibility and will be defined by substrate oxidation (using respiratory exchange ratio) following two standard meals.

Eligibility

Inclusion Criteria:

  • Aged 2 weeks to less than 17 weeks at screening
  • Being fed human milk as a primary source of food
  • Be willing to consume one meal of infant formula
  • Be willing to complete a DXA measurement

Exclusion Criteria:

  • Unable to complete the screening visit and two clinic visits within 14 days
  • Born with health conditions that would render procedures unsafe
  • Born earlier than 35 days and 0 weeks gestation
  • Eating supplemental foods
  • Physician diagnosed feeding difficulties that may require a special type of nipple for bottle feeding

Study details
    Infant Body Composition and Metabolism
    Metabolism
    Energy Expenditure
    Infant Formula
    Human Milk
    Breast Milk
    Metabolic Flexibility

NCT07096011

Pennington Biomedical Research Center

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.